Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report

Saved in:
Bibliographic Details
Published inJournal for immunotherapy of cancer Vol. 9; no. 1
Main Authors Blumendeller, Carolin, Boehme, Julius, Frick, Maximilian, Schulze, Martin, Rinckleb, Antje, Kyzirakos, Christina, Kayser, Simone, Kopp, Maria, Kelkenberg, Sabine, Pieper, Natalia, Bartsch, Oliver, Hadaschick, Dirk, Battke, Florian, Stenzl, Arnulf, Biskup, Saskia
Format Report
LanguageEnglish
Published 01.01.2021
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
content type line 59
SourceType-Reports-1
ObjectType-Report-1
ISSN:2051-1426
DOI:10.1136/jitc-2020-001406